The in-depth analysis shows how custom optical filters outperform standard catalogue options in boosting the performance of scientific and industrial instruments like fluorescence microscopes and spectrophotometers. It explains how tailored filters are designed to meet specific performance requirements, ensuring greater accuracy, reliability, and cost-efficiency. Unlike catalogue filters, custom solutions allow manufacturers to optimize critical parameters such as wavelength range, out-of-band blocking, and physical dimensions, which enhances instrument functionality while reducing complexity. The paper also highlights how custom filters can improve integration, streamline design, and deliver cost-effective solutions, ultimately providing a competitive advantage in specialized applications across various industries.

Gain insight from ICON’s Biotech President, Chris Smyth, on the biggest barriers to success in biotech, and the key strategies required to survive and thrive in this dynamic and competitive landscape. Download the article to gain perspective on the:

Immune checkpoint inhibitors (ICIs) have shown their efficacy, not only as a standalone treatment, but also when combined with traditional methods like chemotherapy and radiation. However, persistent challenges such as high costs and regulatory hurdles still exist. Gain expert knowledge on this novel approach to cancer therapy, with key topics including:

Explore the far-reaching impact of HIV, the latest global research priorities, and the innovative treatments, such as Antiretroviral therapy (ART), that offer hope in finding a cure. Gain insights from CRO experts, Novotech, on key topics, such as:

As technology advances and innovations like digital endpoints and biomarkers become more prevalent, regulatory considerations surrounding them become more complex. Navigate this evolving space, with insights from this free webinar. Experts from Biofourmis will share their insights into:

How can pharma sponsors can successfully navigate the critically important early phase development of their oncology therapies? With 2023’s new FDA Guidance for Dosage Optimization in Oncology Treatment (known as Project Optimus) and the increasingly complex and varied oncology therapies landscape, smart trial design is essential to finding success. Download your free article to discover:

In this webinar, we’ll explore how a contract vivarium, a turnkey research facility with lab equipment, animal husbandry, and technical experts including board-certified veterinarians, offers a hybrid solution to the traditional options of building a vivarium space from scratch or outsourcing to contract research organizations. These environments can be accessed with minimal wait time and come complete with comprehensive services and compliance oversight, so that researchers can quickly start studies and process findings to move assets through the drug development journey. Specific topics will include: Participants will gain insight into:

This webinar will focus on the promising role of these advanced technologies in early drug development, particularly in designing solutions for solubility and bioavailability enhancement. Experts from Thermo Fisher Scientific will discuss the AI/ML-driven technological innovations that are enhancing the efficiency and effectiveness of the early drug development process. Participants will gain insight into:

Free Energy Perturbation (FEP) calculations have developed as a powerful tool to address the critical challenges faced by researchers in drug discovery and molecular modelling to perform accurate prediction of binding free energies. In this webinar, we will explore the benefits of FEP methods in computational chemistry and identify the challenges connected with the application of the method. We will be joined by Dr Sofia Bariami, Product Manager of Flare™ FEP, Cresset, and Dr Barbara Zarzycka, Assistant Professor, Vrije University of Amsterdam. Their conversation will cover: